Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

Dec 11, 2013

30198_dirs_2013-12-11_2901f0ec-ea9e-438c-b687-6a4cadba31b6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-12-09

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-09 Common Stock M 18140.0 $7.27 Acquired 68748 Direct
2013-12-09 Common Stock S 18140.0 $34.4125 Disposed 50608 Direct
2013-12-09 Common Stock M 3244.0 $7.27 Acquired 53852 Direct
2013-12-09 Common Stock S 3244.0 $34.55 Disposed 50608 Direct
2013-12-10 Common Stock S 28157.0 $33.4591 Disposed 22451 Direct
2013-12-10 Common Stock M 48000.0 $7.27 Acquired 70451 Direct
2013-12-10 Common Stock S 48000.0 $33.383 Disposed 22451 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-12-09 Non-Qualified Stock Option (right to buy) $7.27 M 18140.0 Disposed 2019-11-20 Common Stock (18140) Direct
2013-12-09 Non-Qualified Stock Option (right to buy) $7.27 M 3244.0 Disposed 2019-11-20 Common Stock (3244) Direct
2013-12-10 Non-Qualified Stock Option (right to buy) $7.27 M 48000.0 Disposed 2019-11-20 Common Stock (48000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $34.22 to $34.555. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 11,130 unvested restricted stock units, which were granted on May 31, 2013 and shall vest through May 31, 2014.

F3: This transaction was executed in multiple trades at prices ranging from $33.31 to $33.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F4: This transaction was executed in multiple trades at prices ranging from $33.04 to $34.1375. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.